**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
|----------------|--------------------------------------|----------|-----------|
| 584-08-7 |Potassium carbonate | 0.6 | 209-529-3 |
|----------------|--------------------------------------|----------|-----------|
| 1310-58-3 |Potassium hydroxide | 0.2 | 215-181-3 |
|----------------|--------------------------------------|----------|-----------|
| 1332-77-0 |Potassium borate | 0.4 | 215-575-5 |
|----------------|--------------------------------------|----------|-----------|
| 3844-45-9 |C.I. Acid blue 9, disodium salt | 0.02 | 223-339-8 |
|----------------|--------------------------------------|----------|-----------|
| 6381-92-6 |Disodium ethylenediaminetetraacetate d| 1.0 | unlisted |
|----------------|--------------------------------------|----------|-----------|
| 7732-18-5 |Water | 97.78 | 231-791-2 |
+----------------+--------------------------------------+----------+-----------+
Text for R-phrases: see Section 16
Hazard Symbols: None Listed.
Risk Phrases: None Listed.
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Not available.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause mild skin irritation. Low hazard for usual industrial
handling.
Ingestion:
Low hazard for usual industrial handling. May cause gastric
disturbances and electrolytic imbalance.
Inhalation:
May cause respiratory tract irritation. Low hazard for usual
industrial handling.
Chronic:
None
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. If irritation
develops, get medical aid.
Skin:
Get medical aid if irritation develops or persists. Flush skin with
plenty of soap and water.
Ingestion:
If victim is conscious and alert, give 2-4 cupfuls of milk or water.
Wash mouth out with water. Get medical aid if irritation or symptoms
occur.
Inhalation:
Remove from exposure and move to fresh air immediately. If not
breathing, give artificial respiration. Get medical aid if cough or
other symptoms appear.
Notes to Physician:
Antidote:
None reported.
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion.
Extinguishing Media:
Substance is noncombustible; use agent most appropriate to
extinguish surrounding fire. For small fires, use dry chemical,
carbon dioxide, water spray or regular foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth),
then place in suitable container. Clean up spills immediately,
observing precautions in the Protective Equipment section. Provide
ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash hands before eating. Avoid contact with eyes, skin, and
clothing. Keep container tightly closed. Avoid ingestion and
inhalation. Use with adequate ventilation.
Storage:
Store in a cool, dry place. No special precautions indicated.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Use adequate ventilation to keep airborne concentrations low.
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to minimize
contact with skin.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Always use
a NIOSH or European Standard EN 149 approved
respirator when necessary.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Liquid
Color: blue
Odor: odorless
pH: 10.0
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: 212 deg F
Freezing/Melting Point: 32 deg F
Autoignition Temperature: Not applicable.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water: Soluble in water
Specific Gravity/Density: 1.013 @ 25C
Molecular Formula: Mixture
Molecular Weight: Not available
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable.
Conditions to Avoid:
None reported.
Incompatibilities with Other Materials:
None reported.
Hazardous Decomposition Products:
None.
Hazardous Polymerization: Will not occur.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 584-08-7: TS7750000
CAS# 1310-58-3: TT2100000
CAS# 1332-77-0 unlisted.
CAS# 3844-45-9: BQ4725000
CAS# 6381-92-6: AH4410000
CAS# 7732-18-5: ZC0110000
LD50/LC50:
CAS# 584-08-7: Oral, mouse: LD50 = 2570 mg/kg; Oral, rat: LD50 =
1870 mg/kg.
CAS# 1310-58-3: Draize test, rabbit, skin: 50 mg/24H Severe; Oral,
rat: LD50 = 273 mg/kg.
CAS# 1332-77-0.
CAS# 3844-45-9.
CAS# 6381-92-6.
CAS# 7732-18-5: Oral, rat: LD50 = >90 mL/kg.
Carcinogenicity:
Potassium carbonate -
Not listed by ACGIH, IARC, NIOSH, NTP, or OSHA.
Potassium hydroxide -
Not listed by ACGIH, IARC, NIOSH, NTP, or OSHA.
Potassium borate -
Not listed by ACGIH, IARC, NIOSH, NTP, or OSHA.
C.I. Acid blue 9, disodium salt -
Not listed by ACGIH, IARC, NIOSH, NTP, or OSHA.
Disodium ethylenediaminetetraacetate dihydrate -
Not listed by ACGIH, IARC, NIOSH, NTP, or OSHA.
Water -
Not listed by ACGIH, IARC, NIOSH, NTP, or OSHA.
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
Other
No information available.
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
No information available.
IMO
No information available.
RID/ADR
No information available.
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
WGK (Water Danger/Protection)
CAS# 584-08-7: 1
CAS# 1310-58-3: 1
CAS# 1332-77-0: No information available.
CAS# 3844-45-9: 1
CAS# 6381-92-6: 2
CAS# 7732-18-5: No information available.
United Kingdom Occupational Exposure Limits
United Kingdom Maximum Exposure Limits
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 584-08-7 is not listed on Canada's Ingredient Disclosure List.
CAS# 1310-58-3 is not listed on Canada's Ingredient Disclosure List.
CAS# 1332-77-0 is not listed on Canada's Ingredient Disclosure List.
CAS# 3844-45-9 is not listed on Canada's Ingredient Disclosure List.
CAS# 6381-92-6 is not listed on Canada's Ingredient Disclosure List.
CAS# 7732-18-5 is not listed on Canada's Ingredient Disclosure List.
Exposure Limits
CAS# 1310-58-3: OEL-AUSTRALIA:TWA 2 mg/m3
OEL-BELGIUM:STEL 2 mg/m3
OEL-DENMARK:TWA 2 mg/m3
OEL-FINLAND:TWA 2 mg/m3
OEL-FRANCE:STEL 2 mg/m3
OEL-JAPAN:STEL 2 mg/m3
OEL-THE NETHERLANDS:TWA 2 mg/m3
OEL-SWITZERLAND:TWA 2 mg/m3
OEL-UNITED KINGDOM:TWA 2 mg/m3;STEL 2 mg/m3
OEL IN BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV
OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGI TLV
US FEDERAL
TSCA
CAS# 584-08-7 is not listed on the TSCA inventory.
It is for research and development use only.
CAS# 1310-58-3 is not listed on the TSCA inventory.
It is for research and development use only.
CAS# 1332-77-0 is not listed on the TSCA inventory.
It is for research and development use only.
CAS# 3844-45-9 is not listed on the TSCA inventory.
It is for research and development use only.
CAS# 6381-92-6 is not on the TSCA Inventory because it is a hydrate.
It is considered to be listed if the CAS number for the anhydrous form
is on the inventory (40CFR720.3(u)(2)).
CAS# 7732-18-5 is not listed on the TSCA inventory.
It is for research and development use only.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 4/27/1999 Revision #6 Date: 3/10/2004
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
3-Chlorobenzyl Alcohol, 99+%
| 873-63-2 |
|
N-(2-Hydroxyethyl)-1,3-propanediamine, 97+%
| 4461-39-6 |
|
Tetrabutylammonium tetrafluoroborate, 99%
| 429-42-5 |
|
Adamantane, 99+%
| 281-23-2 |
|
3-Carbomethoxy-2-Pyrone, 99% (GC)
| 25991-27-9 |
|
Aflatoxin B2, crystalline
| 7220-81-7 |
|
2,2,6,6-Tetramethyl-4-Piperidone, Monohydrate, 98% (GC)
| 826-35-7 |
|
4-Ethoxymethylene-2-Phenyl-2-Oxazolin- 5-One, 97%
| 15646-46-5 |
|
Drimarene Red Z 2B, 78% (HPLC)
| 15792-41-3 |
|
Carbol Fuchsin Solution
| 64-17-5 |
|
Fehling Solution, Part A
| 7732-18-5 |
|
Buffer Solution pH 10
| 584-08-7 |
|
Buffer Solution pH 7
| 1310-73-2 |
|
4-Normal-Butoxyphenol, 99%
| 122-94-1 |
|
Buffer Solution pH 10.0 (Color-Coded Blue)
| 584-08-7 |
|
9-Methylanthracene, 99%
| 779-02-2 |
|
Phenoxyacetic acid, 98+%
| 122-59-8 |
|
5-(4-Hydroxyphenyl)-5-(p-tolyl)hydantoin, 99%
| 71766-23-9 |
|
Barium Chloranilate Trihydrate
| 13435-46-6 |
|
N-(Trimethylsilyl)acetamide, 97%
| 13435-12-6 |
|
2,4,6-Trimethoxybenzaldehyde, 98%
| 830-79-5 |
|
(1R,2R,3S,5R)-(-)-2,3-Pinanediol, 98%
| 22422-34-0 |
|
Dimethyl Sulfate
| 77-78-1 |
|
6-Hydroxynicotinic Acid, 99%
| 5006-66-6 |
|
2-Chlorocyclohexanone, 95%, Stabilized with CaCO3/MgO
| 822-87-7 |
|
n-Nonylamine, 98%
| 112-20-9 |
|
Oxamic Acid, Sodium Salt, 98%
| 565-73-1 |
|
Alpha-Terthienyl,99+%
| 1081-34-1 |
|
4-Pyridinecarboxaldehyde, 98%
| 872-85-5 |
|
4-3-(Trifluoromethyl)Phenyl??-4-Piperidino L Hydrochloride, 99% (TLC)
| 1683-49-4 |
|
1,3-Diphenylisobenzofuran, 99+%
| 5471-63-6 |
|
(S)-2-??n'-(N-Benzylprolyl)Amino??Benzo-Phenone, 99.5+%
| 96293-17-3 |
|
Sebaconitrile, 98% (GC)
| 1871-96-1 |
|
Tricyclohexyl Phosphine
| 2622-14-2 |
|
3-Ethoxyacrylonitrile, 98+%, mixture of cis and trans
| 61310-53-0 |
|
2-Chloro-5-(trifluoromethyl)pyridine 98+%
| 52334-81-3 |
|
Diisopropyl fluorophosphate
| 55-91-4 |
|
2,3,6-Trichlorobenzaldehyde,98%
| 4659-47-6 |
|
2-Diethylaminoethyl Chloride Hydrochloride, 99.5%
| 869-24-9 |
|
Tetramethylene glutarimide,99%
| 1075-89-4 |
|
1,4-Diacetoxybenzene, 98%
| 1205-91-0 |
|
2-Chloropyrimidine, 98+%
| 1722-12-9 |
|
5(6)-Carboxyfluorescein, 99% (UV-VIS)
| 72088-94-9 |
|
Silver Cyclohexanebutyrate
| 62638-04-4 |
|
1,2-Benzenedimethanol, 97%
| 612-14-6 |
|
4-Nitrobenzamide, 98%
| 619-80-7 |
|
Potassium tri-sec-butylborohydride 1M solution in THF
| 109-99-9 |
|
D(-)-Lyxose, 99+%, Mixture of Anomers
| 1114-34-7 |
|
Neodymium atomic absorption standard solution, 1 mg/ml Nd in 2% HNO3
| 7440-00-8 |
|
1,3-Dihydroxynaphthalene,99+%
| 132-86-5 |
|
|